What You Should Know:
– When developing new drugs, nutritional products, or pesticides, it’s critical that unknown molecules are identified correctly. But accurate identification is a lengthy process and all too often unsuccessful, leading to failed regulatory processes, or worse, consumer health being put in danger.
– Isospec Analytics has raised $1.9M to commercialize new technologies for molecular analysis that rapidly identify unknown molecules in minutes, helping pharmaceuticals, nutrition and agritech companies develop safer products and enabling researchers to discover new biomarkers.
Isospec: Redefining Molecular Analysis for Breakthroughs in Biotech
Founderful (formerly Wingman Ventures) leads Isospec’s $1.9M pre-seed round, joined by specialized investors Tiny.vc, another.vc, and Venture Kick.
Founded in 2022 by Ahmed Ben Faleh, Stephan Warnke, and Thomas Rizzo, Isospec aims to redefine molecular analysis, unlocking new biological insights for diagnostics, therapeutics, and nutrition. Leveraging over 20 years of research, the founders merged technologies from analytical chemistry, photonics, and cryogenic materials originally developed for space applications. This fusion resulted in a groundbreaking tool capable of unveiling previously unknown molecular structures.
Traditional methods of identifying molecules, primarily relying on mass analysis, often fall short. Mass alone cannot definitively determine a molecule’s structure, leading to a time-consuming process of purification and synthesis. Isospec’s technology overcomes this limitation by generating comprehensive metrics that rapidly identify unknown molecules, revolutionizing molecular identification with scalability and speed.
By integrating infrared analysis directly into mass spectrometry, Isospec enhances molecule identification, enabling swift and precise analysis in minutes rather than months. Originating from EPFL’s Laboratory of Molecular Physical Chemistry, their technology is already revolutionizing quality control and R&D in the food and agritech industries.
Currently focused on platform scalability, Isospec is introducing automation and machine learning tools for enhanced data analysis. Positioned within the competitive landscape of sugar and metabolite analytics, Isospec aims to lead the way in molecular analysis and biomarker discovery for therapeutics and diagnostics.
